Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.
about
Doxycycline ameliorates the susceptibility to aortic lesions in a mouse model for the vascular type of Ehlers-Danlos syndromeEducational paper. Connective tissue disorders with vascular involvement: from gene to therapyNeurological manifestations of Ehlers-Danlos syndrome(s): A reviewConditions presenting with symptoms of peripheral arterial diseaseNew Insights Into Aortic Diseases: A Report From the Third International Meeting on Aortic Diseases (IMAD3)Spontaneous colon perforations associated with a vascular type of ehlers-danlos syndrome.Molecular diagnosis in vascular Ehlers-Danlos syndrome predicts pattern of arterial involvement and outcomes.Allele-specific siRNA knockdown as a personalized treatment strategy for vascular Ehlers-Danlos syndrome in human fibroblastsChronic treatment with a broad-spectrum metalloproteinase inhibitor, doxycycline, prevents the development of spontaneous aortic lesions in a mouse model of vascular Ehlers-Danlos syndrome.Clinical utility gene card for: Ehlers-Danlos syndrome types I-VII and variants - update 2012Genetic dissection of marfan syndrome and related connective tissue disorders: an update 2012.Vascular-type Ehlers-Danlos syndrome caused by a hitherto unknown genetic mutation: a case reportVascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family.Postpartum spontaneous coronary, vertebral, and mesenteric artery dissections: a case report.Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration.A combined vascular surgical and clinical genetics approach to diffuse aneurysmal disease.Advances in stroke care and research in 2010.β-Adrenergic blockers.Pharmacological modulation of arterial stiffness.Varying presentations in patients with symptomatic type IV vascular Ehlers-Danlos syndrome.The Ehlers-Danlos syndrome, a disorder with many faces.Are we ignoring the dilated thoracic aorta?The collagenopathies: review of clinical phenotypes and molecular correlations.Ehlers-Danlos syndrome: how to diagnose and when to perform genetic tests.Managing aortic aneurysms and dissections during pregnancy.Genetics of hereditary large vessel diseases.The spectrum of spontaneous coronary artery dissection: illustrated review of the literature.Genes in Thoracic Aortic Aneurysms and Dissections - Do they Matter?: Translation and Integration of Research and Modern Genetic Techniques into Daily Clinical Practice.Recurrent Abdominal Arterial Aneurysm Rupture.Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Pediatric Cardiology (SICP), and Italian Society of Gynaecologists and Obstetrics (SIGO): pregnancy and congenital heart diseases.Celiprolol: A Unique Selective Adrenoceptor Modulator.Spontaneous Dissection of the Renal Artery in Vascular Ehlers-Danlos Syndrome.Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report.Genes in thoracic aortic aneurysms/dissections - do they matter?Vascular Ehlers-Danlos syndrome: exploring the role of inflammation in arterial disease.A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.Ehlers-Danlos syndrome, vascular type: a novel missense mutation in the COL3A1 gene.Pharmacology and drug development in rare diseases: the attractiveness and expertise of the French medical pharmacology.Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease.Vascular phenotypes in nonvascular subtypes of the Ehlers-Danlos syndrome: a systematic review.
P2860
Q24631384-39545AB8-7305-4765-BFF9-2A9BF8449422Q26853455-215BA694-0399-4786-B1AC-EAB6EADA02ECQ28088448-57FADCAF-B3FD-4AF4-AC24-17CFAD3492C1Q30301251-22D2C540-3BD3-4176-AA41-2F3510EA0120Q30393291-30E62C92-5490-4118-8084-D08708D3C682Q33724686-60C72FC7-0579-4797-A28E-83F5B5AE1C78Q35402977-5F0168CE-9DE5-4F8E-9366-DEF5B53BB3DBQ35790300-C6A98BF7-56E5-4F46-94B3-67A2AE03E09CQ36296835-CB80F15F-E508-45B1-BC30-7FA312F75AA1Q36497322-C93F102F-2FB7-4DA0-999D-E303EAFC2E20Q36526049-7FECA19D-3BA9-403D-A7C9-E025D8DBFD4FQ36597166-F2FD2FCF-5D51-4EDC-969E-5D013A4D7891Q36695229-BD4D4021-4B44-486D-A80A-0DCB41F06B3AQ36980892-C13D6438-489A-4BA5-A612-542D44B95DBDQ37148384-2D524F6F-0E33-4BF1-A24D-60257C35977DQ37395241-B6D5AB27-4248-422A-909D-BADE0FE90127Q37896682-ADAE91C1-481B-4BD3-8E0C-9BD5763F8628Q37928128-E1B4356E-39BB-4207-944A-81A050727F09Q37929160-F1B0C5D1-A941-4EDD-9DE7-EDBFC5E6C0E1Q37981654-FE1A9116-01D9-4F0A-B9BF-F480D1CBB3FEQ37986887-7759BDF0-F611-4C8C-A79C-93344DC832A6Q38006747-2DA1181D-BC61-4F11-8EB6-1C2AE2DF3C61Q38171408-E605BB0B-F100-4D48-9AB4-5AAEE04FC6A2Q38226265-C09D0CEC-B76A-47D9-BB2D-C2103C34D77EQ38497709-2FE0ED68-DFBE-4C1F-80A8-89010D7F93A2Q38601760-7DF6FDF0-72D2-49D8-ABDD-181EC4EDD132Q39402194-ABF56A41-D502-40E6-BC56-0B8E6C23BB1CQ40074360-46CC5ACB-8080-4C7C-B498-223768F60B1EQ40834076-2F2FDAAB-7A76-4970-807A-170F66B5A857Q41118476-4F90E2F0-7861-48DD-A4C3-BEF1D022FB13Q41322349-438D10B9-C2C6-498F-999D-86B4A90E8F79Q41615271-71E40E4C-25AE-4E32-90C3-19C8D3F6793CQ42124683-B7DE5790-9C58-4EA6-8730-5378AD1CB799Q42226301-C838BB5E-D66A-455C-8A2D-517E45D1ACFAQ43150240-57D05BC0-D413-458C-8CA8-2DA9EA118A71Q44061893-14FABCD7-E472-43C9-9533-E0122A7EC9A0Q46556412-CB2ED7DB-528B-45D6-BF96-9EFF4E415820Q47304122-5D5C217B-F67E-4BCD-B8C2-D60A5305C8CCQ47734987-93AF5BE7-4B1F-4653-9009-51EB9B704F36Q47859621-B5CE971E-5D7F-4FA9-9E45-342B5B52FCD3
P2860
Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@ast
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@en
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@nl
type
label
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@ast
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@en
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@nl
prefLabel
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@ast
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@en
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@nl
P2093
P50
P1433
P1476
Effect of celiprolol on preven ...... open, blinded-endpoints trial.
@en
P2093
Anne-Laure Fauret
Dominique P Germain
Erwan Bozec
Gabriella Georgesco
Henri Plauchu
Jean-Noël Fiessinger
Jean-Sebastien Hulot
Joseph Emmerich
Jérôme Perdu
Kim-Thanh Ong
P304
P356
10.1016/S0140-6736(10)60960-9
P407
P577
2010-09-07T00:00:00Z